World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
40232
World Ranking
6554
National Ranking
251

Dirk De Ruysscher publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dirk De Ruysscher sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 887 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dirk De Ruysscher D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dirk De Ruysscher sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Dirk De Ruysscher is affiliated with Maastricht University in the Netherlands and has an extensive research portfolio primarily in medicine, with a particular focus on pulmonary and respiratory medicine. Their work spans over 323 publications, covering significant areas such as oncology, radiology, nuclear medicine, and epidemiology.

Their research topics are centered on lung cancer, specifically in diagnosis, treatment, and mutations. Additionally, their work explores advanced radiotherapy techniques, radiomics and machine learning in medical imaging, cancer immunotherapy, biomarkers, and medical imaging techniques and applications.

  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Research Studies
  • Advanced Radiotherapy Techniques
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Immunotherapy and Biomarkers
  • Medical Imaging Techniques and Applications

They have published extensively in key journals in their field, including the following frequent publication venues:

  • Radiotherapy and Oncology
  • Annals of Oncology
  • Lung Cancer
  • Journal of Thoracic Oncology
  • International Journal of Radiation Oncology*Biology*Physics

Among their frequently collaborating co-authors are Lizza Hendriks, Maarten Lambrecht, Corinne Faivre-Finn, Stéphanie Peeters, and Petra Seibold, reflecting sustained partnerships in their research network.

Some recent notable papers authored or co-authored by Dirk De Ruysscher include:

  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus, 2020, Annals of Oncology
  • ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma, 2020, European Respiratory Journal
  • Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology, 2020, OncoImmunology
  • Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14), 2020, Journal of Thoracic Oncology

Best Publications

  • Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    J. Vansteenkiste;D. De Ruysscher;W.E.E. Eberhardt;E. Lim

  • Small Cell Lung Cancer

    Jan P van Meerbeeck;Dean A Fennell;Dirk K M De Ruysscher

  • ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)

    Alessandro Brunelli;Anne Charloux;Chris Thomas Bolliger;Gaetano Rocco

  • Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    M Reck;S Popat;N Reinmuth;Dirk De Ruysscher

  • Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    M Früh;Dirk De Ruysscher;S Popat;L Crinò

  • The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

    Kobe Reynders;Tim Illidge;Shankar Siva;Shankar Siva;Joe Y. Chang

  • 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    J. Vansteenkiste;L. Crinò;C. Dooms;J. Y. Douillard

  • Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach.

    Johannes A. Langendijk;Philippe Lambin;Dirk De Ruysscher;Joachim Widder

  • 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    W.E.E. Eberhardt;D. De Ruysscher;W. Weder;C. Le Péchoux

  • Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

    Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

  • Predicting outcomes in radiation oncology--multifactorial decision support systems

    Philippe Lambin;Ruud G. P. M. van Stiphout;Maud H. W. Starmans;Emmanuel Rios-Velazquez

  • Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer

    Dirk De Ruysscher;Madelon Pijls-Johannesma;Søren M. Bentzen;André Minken

  • Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis

    Janneke P.C. Grutters;Alfons G.H. Kessels;Madelon Pijls-Johannesma;Dirk De Ruysscher

  • Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non–Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)

    Wilfried Ernst Erich Eberhardt;Christoph Pöttgen;Thomas Christoph Gauler;Godehard Friedel

  • Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures.

    Ruben T H M Larue;Gilles Defraene;Dirk De Ruysscher;Philippe Lambin

  • Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)

    Dirk De Ruysscher;Rinus Wanders;Angela van Baardwijk;Anne-Marie C. Dingemans

  • Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

    Keith M. Kerr;Lukas Bubendorf;Martin J. Edelman;Antonio Marchetti

  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    A.-M.C. Dingemans;M. Früh;A. Ardizzoni;B. Besse

  • European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer

    Dirk De Ruysscher;Corinne Faivre-Finn;Ursula Nestle;Coen W. Hurkmans

  • PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.

    Angela van Baardwijk;Geert Bosmans;Liesbeth Boersma;Jeroen Buijsen

Frequent Co-Authors

Philippe Lambin
Philippe Lambin Maastricht University
Anne-Marie C. Dingemans
Anne-Marie C. Dingemans Erasmus University Rotterdam
Hugo J.W.L. Aerts
Hugo J.W.L. Aerts Brigham and Women's Hospital
Søren M. Bentzen
Søren M. Bentzen University of Maryland, Baltimore
Cécile Le Péchoux
Cécile Le Péchoux Institut Gustave Roussy
Solange Peters
Solange Peters University Hospital of Lausanne
Catharine M L West
Catharine M L West University of Manchester
Manuela A. Joore
Manuela A. Joore Maastricht University Medical Centre
Alison M. Dunning
Alison M. Dunning University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For aspiring medical professionals or those looking to expand their expertise, numerous online degree options offer flexibility and career advancement. Some students interested in healthcare may choose to diversify their background before or during medical school. For example, earning a degree through the best online food science degree programs can open doors in nutrition, food safety, and public health nutrition, all of which complement medical training.

If healthcare management is your goal, consider enrolling in online mha programs cahme accredited to prepare for leadership in hospital or clinical settings. For registered nurses seeking further credentialing, there are rn to bsn online programs without clinicals that allow working professionals to advance their education while balancing current employment.

Finally, nurses looking for the fastest path to a doctoral degree can explore the fastest dnp program options online to reach the highest levels of practice and research. Each of these pathways can support a successful and flexible journey in the medical field, whether you’re preparing for medical school, advancing your current role, or exploring alternative healthcare careers.

Best Scientists Citing Dirk De Ruysscher

Trending Scientists

Recently Published Articles